Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Epix falls on MS-325 delay

EPIX was off $2.84 (36%) to $5.01 on Friday. On

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE